These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31660841)

  • 1. Mycophenolate Mofetil-induced Oral Ulcerations in a Kidney Transplant Recipient.
    Gaied H; Bacha MM; Mesbahi T; Ounissi M; Aoudia R; Jerbi M; Jones M; Ksantini M; Rammeh S; Hedri H; Goucha R; Abdallah TB
    Curr Drug Saf; 2020; 15(1):73-76. PubMed ID: 31660841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ulcerations as a sequela of tacrolimus and mycophenolate mofetil therapy.
    Philipone E; Rockafellow A; Sternberg R; Yoon A; Koslovsky D
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Dec; 118(6):e175-8. PubMed ID: 25457894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate-induced oral ulcers: Case report and literature review.
    Asare K; Gatzke CB
    Am J Health Syst Pharm; 2020 Mar; 77(7):523-528. PubMed ID: 32058566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of oral ulcerations associated with mycophenolate mofetil in kidney transplantation.
    Tenório JR; Tuma M; Martins F; Ortega KL; Cristelli M; Gallottini M
    Spec Care Dentist; 2020 Nov; 40(6):605-610. PubMed ID: 32950040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.
    van Gelder T; ter Meulen CG; Hené R; Weimar W; Hoitsma A
    Transplantation; 2003 Mar; 75(6):788-91. PubMed ID: 12660502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil-induced mouth ulcers in a kidney transplant patient: Case report and literature review.
    Plana-Pla A; Solé LC; Garcia AB; Valdemoros RL
    Nefrologia (Engl Ed); 2019; 39(1):80-83. PubMed ID: 30082101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ulcers associated with mycophenolate mofetil use in a renal transplant recipient.
    Weng RR; Foster CE; Hsieh LL; Patel PR
    Am J Health Syst Pharm; 2011 Apr; 68(7):585-8. PubMed ID: 21411799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ulcers produced by mycophenolate mofetil in two liver transplant patients.
    Naranjo J; Poniachik J; Cisco D; Contreras J; Oksenberg D; Valera JM; Díaz JC; Rojas J; Cardemil G; Mena S; Castillo J; Rencoret G; Godoy J; Escobar J; Rodríguez J; Leyton P; Fica A; Toledo C
    Transplant Proc; 2007 Apr; 39(3):612-4. PubMed ID: 17445557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
    Miller J; Mendez R; Pirsch JD; Jensik SC
    Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients.
    Guo YW; Gu HY; Abassa KK; Lin XY; Wei XQ
    World J Gastroenterol; 2016 Jun; 22(24):5616-22. PubMed ID: 27350740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil in pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; Wrenshall L; Humar A; Gruessner AC
    Transplantation; 1998 Aug; 66(3):318-23. PubMed ID: 9721799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
    Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
    Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral ulcerations in a renal transplant recipient: a mycophenolate mofetil-induced complication?
    Garrigue V; Canet S; Dereure O; Panabieres O; Augias D; Chong G; Mourad G
    Transplantation; 2001 Sep; 72(5):968-9. PubMed ID: 11571473
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
    Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J
    Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric-coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal-transplant recipients compared with mycophenolate mofetil.
    Feng JJ; Zhang LW; Zhao P; Bow LM; Tian J
    Int J Clin Pract Suppl; 2015 May; (183):1-7. PubMed ID: 26176848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does mycophenolate mofetil increase the incidence of infections in stable renal transplant recipients initially treated with a two-drug regimen?
    Chen Y; Chu SH; Wei TY; Yen TH; Chiang YJ; Wu CT; Chen HW
    Transplant Proc; 2004 Sep; 36(7):2122-3. PubMed ID: 15518769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.